Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease
COMBAT-CAD
1 other identifier
observational
850
1 country
1
Brief Summary
Main aim of the COMBAT-CAD-Study is to clarify, if the combination of stress testing with biomarkers improves the diagnostic accuracy. Hypothesis of our study is that diagnosis of CAD can be improved by adding biomarkers to solely stress testing for the workup of patients with suspected CAD or progress of already known CAD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2017
CompletedFirst Submitted
Initial submission to the registry
April 28, 2017
CompletedFirst Posted
Study publicly available on registry
May 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedMay 31, 2022
May 1, 2022
4.7 years
April 28, 2017
May 27, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis of coronary artery disease
The diagnosis of coronary artery disease through stress testing alone and combined with cardiac biomarkers.
Within the initial diagnostic evaluation process (maximum within 30 days)
Eligibility Criteria
Eligible are all patients who receive stress testing ordered by a physician of the University Heart Center and who are willing and able to participate in an observational study. Participants of interest are outpatients and inpatients of the University Heart Centre.
You may qualify if:
- \. Every patient referred to coronary angiography, or diagnostic work-up with suspicion of CAD or progress of CAD (in case of CABG patients or already treated with PCI)
You may not qualify if:
- Insufficient knowledge of the German language (able to understand and write the German language)
- Physical or psychological incapability to take part in the investigation
- Persons with no sufficient language ability in German to understand the provided study information material.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General and Interventional Cardiology, University Heart Center Hamburg
Hamburg, 20246, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Blankenberg, MD
Head of the Department
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2017
First Posted
May 2, 2017
Study Start
April 12, 2017
Primary Completion
December 31, 2021
Study Completion
April 30, 2022
Last Updated
May 31, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share